Abstract
We review antifungal susceptibility testing and the development of clinical breakpoints, and detail an approach to using antifungal susceptibility results when breakpoints have not been defined. This information may prove helpful when selecting therapy for invasive fungal infections in children.
| Original language | English |
|---|---|
| Journal | Journal of the Pediatric Infectious Diseases Society |
| Volume | 12 |
| Issue number | 4 |
| Pages (from-to) | 214-221 |
| Number of pages | 8 |
| ISSN | 2048-7193 |
| DOIs | |
| Publication status | Published - 28 Apr 2023 |
Keywords
- Antifungal Agents/pharmacology
- Candida
- Fluconazole
- Humans
- Microbial Sensitivity Tests
- invasive fungal disease
- broth microdilution
- clinical breakpoint
- epidemiological cutoff value
- minimum inhibitory concentration
Fingerprint
Dive into the research topics of 'A Practical Guide to Antifungal Susceptibility Testing'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS